Drug
Cv9202
Cv9202: highest development phase Phase 1, developed by CureVac. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CureVac
Trials
| Drug | Phase | Indication |
|---|---|---|
| CV9202 NCT01915524 | Phase 1 | Non-Small Cell Lung Carcinoma |
Latest
No recent events.
Follow Cv9202 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.